Tenderwize
Back to tender search

Open house discount agreements Pegfilgrastim ATC L03AA13

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Oct 03, 2027 · 412 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Pegfilgrastim, ATC L03AA13

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

The discount agreement does not commit AOK Bayern to purchase any volume. The commercial benefit depends entirely on pr...

If a national or regional framework agreement for Pegfilgrastim is concluded through a formal procurement, the open-hou...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Nov 2027
  • Supply of pharmaceutical products containing Pegfilgrastim (ATC L03AA13)
  • Non-exclusive discount agreements (Rabattverträge) under §130a Abs. 8 SGB V
Show full summary

This is an open-house model (not a standard procurement procedure) by AOK Bayern for non-exclusive discount agreements on the active substance Pegfilgrastim (ATC L03AA13). All eligible pharmaceutical companies can enter into identical, non-negotiable discount agreements. The contract period is from 1 December 2025 to 30 November 2027, with any-time joining possible until 3 October 2027. No estimated value is provided. The procedure is not subject to procurement law, and no selection/award criteria apply – participation is open to all qualified pharmaceutical undertakings.

Risks

The discount agreement does not commit AOK Bayern to purchase any volume. The commercial benefit depends entirely on pr...

If a national or regional framework agreement for Pegfilgrastim is concluded through a formal procurement, the open-hou...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical undertakings (pharmazeutische Unternehmen) are eligible to participate

Administrative

  • Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
  • Submission of the signed contract including an annex listing the specific medicinal products

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house discount agreements Pegfilgrastim ATC L03AA13

Non-exclusive discount agreement for the active substance Pegfilgrastim (ATC L03AA13) with AOK Bayern. All eligible pharmaceutical companies can join at any time during the contract period.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Nov 2025 - Nov 2027

Category

Pharmaceutical products

Deadline

Deadline Oct 03, 2027

Procurement Details

Publication date
13 Oct 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
673779-2025

Documents (2)

Similar tenders